Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435260
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-24
Brief Title:
To Explore the Efficacy of Hypofractionated Radiotherapy Followed by AG Regimen Chemotherapy Plus Camrelizumab Immunotherapy as Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Organization Data
Organization:
Hebei Medical University Fourth Hospital
Class:
OTHER
Study ID:
ARK-pancreatic-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hebei Medical University Fourth Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None